ESR1 and triple-negative breast carcinoma: Breast cancer subtypes investigated among the articles found among this review included luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) +/-, estrogen receptor (ER) +/-, progesterone receptor (PR) +/-, and triple negative breast cancer (TNBC).